William Scott

Corporate Officer/Principal at

The Rockefeller University

86 year

78 connections

Health Technology

Commercial Services

Consumer Services

Profile

Dr. William A. Scott has extensive research and management experience in both biotechnology and large pharmaceutical companies.
Bill was previously Chief Executive Officer of Physiome Sciences, Inc., a company whose mission is to help pharmaceutical companies develop better drugs faster through the use of biological simulations.
Prior to that, he held various senior level positions at Bristol-Myers Squibb (“BMS”) including Senior Vice President, Exploratory and Drug Discovery Research at BMS Pharmaceutical Research Institute from 1990 through 1996.
During this period, he oversaw the submission of over 70 new chemical entities for development as new therapeutic agents.
He consults or serves as a member of the board of directors of several biotechnology companies, including serving on the boards of publicly-traded AtheroGenics, Inc., Deltagen, Inc. and Variagenics, Inc. Bill holds a B.S.
in Chemistry from University of Illinois and a Ph.D.
in Biochemistry from the California Institute of Technology.
He is also an Adjunct Professor at the Rockefeller University, where he has been affiliated since 1969.

William Scott active positions

Companies	Position	Start
The Rockefeller University The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1968-12-31
KBL Healthcare Ventures KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements.	Consultant / Advisor	-

All active positions of William Scott

Former positions of William Scott

Companies	Position	End
AtheroGenics, Inc. AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases	Director/Board Member	2009-07-13
Variagenics, Inc. Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics	Director/Board Member	2006-11-14
Physiome Sciences, Inc. Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development	President	1998-12-31
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	1996-12-30
CombiChem, Inc. CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug recovery services	Director/Board Member	-

See the detail of William Scott's experience

Training of William Scott

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Scott's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
CombiChem, Inc. CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug recovery services	Commercial Services
AtheroGenics, Inc. AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases	Health Technology
Deltagen, Inc. Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry	Commercial Services
VenGrowth Capital Partners, Inc. VenGrowth Capital Partners, Inc. Investment ManagersFinance The VenGrowth Funds invest in small and mid-sized private Canadian companies in the technology, life sciences and tradition industries sectors. The Criterion Global Dividend Fund invests in blue-chip multinational companies selected by Merrill Lynch International. The Fund is also available unhedged. The Criterion International Equity Fund is actively sub-advised by The Boston Company. The Fund invests in international stocks outside of North America, with a GARP strategy. It is also available unhedged. The Criterion Water Infrastructure Fund invests globally in companies related to water delivery. The Fund is also available unhedged. The Criterion Global Clean Energy Fund invests in companies involved in the global transition to cleaner energies and lower carbon emissions. The Fund is also available unhedged. The Criterion Diversified Commodities Currency Hedged Fund allows Canadian investors to participate directly in the diversified commodities index UBS Bloomberg CMCI AM. The Criterion US Buyback Fund invests in US companies with the best record of net share buybacks. It is also available unhedged.	Finance
Variagenics, Inc. Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics	Commercial Services
Physiome Sciences, Inc. Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development	Commercial Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avalon Pharmaceuticals, Inc. Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products	Health Technology
KBL Healthcare Ventures KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements.	Finance
Targanta Therapeutics, Inc. Targanta Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotic drugs and other related products	Health Technology
The Rockefeller University The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services